Literature DB >> 23329000

Isolation and analysis of brain-sequestered leukocytes from Plasmodium berghei ANKA-infected mice.

Victoria Ryg-Cornejo1, Lisa J Ioannidis, Diana S Hansen.   

Abstract

We describe a method for isolation and characterization of adherent inflammatory cells from brain blood vessels of P. berghei ANKA-infected mice. Infection of susceptible mouse-strains with this parasite strain results in the induction of experimental cerebral malaria, a neurologic syndrome that recapitulates certain important aspects of Plasmodium falciparum-mediated severe malaria in humans. Mature forms of blood-stage malaria express parasitic proteins on the surface of the infected erythrocyte, which allows them to bind to vascular endothelial cells. This process induces obstructions in blood flow, resulting in hypoxia and haemorrhages and also stimulates the recruitment of inflammatory leukocytes to the site of parasite sequestration. Unlike other infections, i.e neutrotopic viruses, both malaria-parasitized red blood cells (pRBC) as well as associated inflammatory leukocytes remain sequestered within blood vessels rather than infiltrating the brain parenchyma. Thus to avoid contamination of sequestered leukocytes with non-inflammatory circulating cells, extensive intracardial perfusion of infected-mice prior to organ extraction and tissue processing is required in this procedure to remove the blood compartment. After perfusion, brains are harvested and dissected in small pieces. The tissue structure is further disrupted by enzymatic treatment with Collagenase D and DNAse I. The resulting brain homogenate is then centrifuged on a Percoll gradient that allows separation of brain-sequestered leukocytes (BSL) from myelin and other tissue debris. Isolated cells are then washed, counted using a hemocytometer and stained with fluorescent antibodies for subsequent analysis by flow cytometry. This procedure allows comprehensive phenotypic characterization of inflammatory leukocytes migrating to the brain in response to various stimuli, including stroke as well as viral or parasitic infections. The method also provides a useful tool for assessment of novel anti-inflammatory treatments in pre-clinical animal models.

Entities:  

Mesh:

Year:  2013        PMID: 23329000      PMCID: PMC3582690          DOI: 10.3791/50112

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

Review 1.  Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis.

Authors:  J Brian de Souza; Eleanor M Riley
Journal:  Microbes Infect       Date:  2002-03       Impact factor: 2.700

Review 2.  Immunological processes in malaria pathogenesis.

Authors:  Louis Schofield; Georges E Grau
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

3.  Isolation of brain-infiltrating leukocytes.

Authors:  Reghann G LaFrance-Corey; Charles L Howe
Journal:  J Vis Exp       Date:  2011-06-13       Impact factor: 1.355

Review 4.  The pathogenic basis of malaria.

Authors:  Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

5.  Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Authors:  Gabriele S V Campanella; Andrew M Tager; Joseph K El Khoury; Seddon Y Thomas; Tabitha A Abrazinski; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

6.  Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells.

Authors:  Rachel J Lundie; Tania F de Koning-Ward; Gayle M Davey; Catherine Q Nie; Diana S Hansen; Lei Shong Lau; Justine D Mintern; Gabrielle T Belz; Louis Schofield; Francis R Carbone; Jose A Villadangos; Brendan S Crabb; William R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-17       Impact factor: 11.205

7.  NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria.

Authors:  Diana S Hansen; Nicholas J Bernard; Catherine Q Nie; Louis Schofield
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

8.  A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.

Authors:  Fiona H Amante; Amanda C Stanley; Louise M Randall; Yonghong Zhou; Ashraful Haque; Karli McSweeney; Andrew P Waters; Chris J Janse; Michael F Good; Geoff R Hill; Christian R Engwerda
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

9.  Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain.

Authors:  Charles L Howe; Reghann G Lafrance-Corey; Rhianna S Sundsbak; Stephanie J Lafrance
Journal:  J Neuroinflammation       Date:  2012-03-09       Impact factor: 8.322

10.  IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection.

Authors:  Catherine Q Nie; Nicholas J Bernard; M Ursula Norman; Fiona H Amante; Rachel J Lundie; Brendan S Crabb; William R Heath; Christian R Engwerda; Michael J Hickey; Louis Schofield; Diana S Hansen
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more
  2 in total

1.  miR-98 reduces endothelial dysfunction by protecting blood-brain barrier (BBB) and improves neurological outcomes in mouse ischemia/reperfusion stroke model.

Authors:  David L Bernstein; Viviana Zuluaga-Ramirez; Sachin Gajghate; Nancy L Reichenbach; Boris Polyak; Yuri Persidsky; Slava Rom
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-10       Impact factor: 6.200

2.  Malaria parasite heme biosynthesis promotes and griseofulvin protects against cerebral malaria in mice.

Authors:  Manjunatha Chandana; Aditya Anand; Sourav Ghosh; Rahul Das; Subhashree Beura; Sarita Jena; Amol Ratnakar Suryawanshi; Govindarajan Padmanaban; Viswanathan Arun Nagaraj
Journal:  Nat Commun       Date:  2022-07-12       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.